These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 23600397)
21. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine. Vearrier D; Greenberg MI; Miller SN; Okaneku JT; Haggerty DA Dis Mon; 2012 Feb; 58(2):38-89. PubMed ID: 22251899 [No Abstract] [Full Text] [Related]
22. Methamphetamine: geographic areas and populations at risk, and emerging evidence for effective interventions. Degenhardt L; Baker A; Maher L Drug Alcohol Rev; 2008 May; 27(3):217-9. PubMed ID: 18368601 [No Abstract] [Full Text] [Related]
23. [Spontaneous recrudescence of psychotic diseases caused by methamphetamine (a stimulant): the stress type and the role of noradrenaline and dopamine systems]. Aburai K; Ikemoto U; Goto K Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Oct; 24(5):319-20. PubMed ID: 15658512 [No Abstract] [Full Text] [Related]
24. Developmental neurotoxicity - challenges in the 21st century and in vitro opportunities. Smirnova L; Hogberg HT; Leist M; Hartung T ALTEX; 2014; 31(2):129-56. PubMed ID: 24687333 [TBL] [Abstract][Full Text] [Related]
25. The methamphetamine epidemic and dentistry. Klasser GD; Epstein JB Gen Dent; 2006; 54(6):431-9; quiz 440, 448. PubMed ID: 17134084 [TBL] [Abstract][Full Text] [Related]
26. International STakeholder NETwork (ISTNET) for creating a developmental neurotoxicity testing (DNT) roadmap for regulatory purposes. Crofton K; Fritsche E; Ylikomi T; Bal-Price A ALTEX; 2014; 31(2):223-4. PubMed ID: 24794006 [No Abstract] [Full Text] [Related]
27. A harmless high? Sammler EM; Foley PL; Lauder GD; Wilson SJ; Goudie AR; O'Riordan JI Lancet; 2010 Aug; 376(9742):742. PubMed ID: 20801405 [No Abstract] [Full Text] [Related]
29. [Current data on methamphetamine]. Cottencin O; Rolland B; Guardia D; Karila L Rev Prat; 2012 May; 62(5):679-81. PubMed ID: 22730802 [TBL] [Abstract][Full Text] [Related]
30. The effect of gender and the neurotrophin, BDNF, upon methamphetamine-induced neurotoxicity of the nigrostriatal dopaminergic system in mice. Dluzen DE Neurosci Lett; 2004 Apr; 359(3):135-8. PubMed ID: 15050682 [TBL] [Abstract][Full Text] [Related]
31. Risk assessment of an essential element: manganese. Santamaria AB; Sulsky SI J Toxicol Environ Health A; 2010; 73(2):128-55. PubMed ID: 20077284 [TBL] [Abstract][Full Text] [Related]
32. Incidence of Hypermanganesemia in Children Who Are Administered Parenteral Nutrition. Greene E; Shokur R; Brown L; Petros A; Raman S JPEN J Parenter Enteral Nutr; 2016 Aug; 40(6):766-7. PubMed ID: 27440414 [No Abstract] [Full Text] [Related]
33. Triple trouble: cognitive deficits from hepatitis C, HIV, and methamphetamine. van Gorp WG; Hinkin CH Neurology; 2005 Apr; 64(8):1328-9. PubMed ID: 15851716 [No Abstract] [Full Text] [Related]
34. Mutual enhancement of central neurotoxicity induced by ketamine followed by methamphetamine. Ke JJ; Chen HI; Jen CJ; Kuo YM; Cherng CG; Tsai YP; Ho MC; Tsai CW; Yu L Toxicol Appl Pharmacol; 2008 Mar; 227(2):239-47. PubMed ID: 18076959 [TBL] [Abstract][Full Text] [Related]
35. Manganese neurotoxicity: connecting the dots along the continuum of dysfunction. Martin CJ Neurotoxicology; 2006 May; 27(3):347-9. PubMed ID: 16337002 [TBL] [Abstract][Full Text] [Related]